SLC7A11 and metabolic dysfunction-associated steatotic liver disease: Thus, our data suggested that SLC7A11 mediates GSH synthesis and reduces the susceptibility of liver cells to oxidative stress, as well as ferroptosis, thereby alleviating the development and progression of NAFLD.